| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/07/2023 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 10k | $2.85 | $28.5k | | 06/07/2023 |
| 06/07/2023 | Omega Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 18.1k | $8.39 | $152k | | 06/07/2023 |
| 06/30/2022 | Protara Therapeutics, Inc. | PRTO | Purchase | Common Stock | 10k | $3.10 | $31k | | 06/30/2022 |
| 06/08/2022 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 10k | $3.50 | $35k | | 06/08/2022 |
| 06/08/2022 | Omega Therapeutics, Inc. | | Grant | Option (Right to Buy) | 18.1k | $3.31 | $60k | | 06/08/2022 |
| 03/14/2022 | Protara Therapeutics, Inc. | PRTO | Purchase | Common Stock | 10k | $4.25 | $42.5k | | 03/14/2022 |
| 03/10/2022 | Protara Therapeutics, Inc. | PRTO | Purchase | Common Stock | 10k | $4.46 | $44.6k | | 03/10/2022 |
| 11/17/2021 | Trillium Therapeutics Inc. | TRIL | Disposition | Deferred Share Unit | 547.7k | $0.00 | $0 | | 11/17/2021 |
| 11/17/2021 | Trillium Therapeutics Inc. | TRIL | Disposition | Stock Option (Right to Buy) | 6.7k | $0.00 | $0 | | 11/17/2021 |
| 11/17/2021 | Trillium Therapeutics Inc. | TRIL | Disposition | Stock Option (Right to Buy) | 40k | $12.03 | $481.2k | | 11/17/2021 |
| 07/29/2021 | Omega Therapeutics, Inc. | | Grant | Stock Option (Right to Buy) | 52.9k | $17.00 | $900k | | 07/29/2021 |
| 06/09/2021 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 10k | $10.51 | $105.1k | | 06/09/2021 |
| 06/04/2021 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 10k | $35.52 | $355.2k | | 06/04/2021 |
| 06/09/2020 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 9k | $35.00 | $315k | | 06/09/2020 |
| 05/29/2020 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 10k | $37.66 | $376.6k | | 05/29/2020 |
| 01/10/2020 | Protara Therapeutics, Inc. | PRTO | Grant | Common Stock | 168k | $0.00 | $0 | | 01/09/2020 |
| 01/09/2020 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 12.4k | $9.18 | $113.8k | | 01/09/2020 |
| 01/09/2020 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 6.7k | $9.18 | $61.3k | | 01/09/2020 |
| 01/09/2020 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 12.4k | $9.18 | $113.8k | | 01/09/2020 |
| 01/09/2020 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 6.7k | $9.18 | $61.3k | | 01/09/2020 |
| 01/09/2020 | Protara Therapeutics, Inc. | PRTO | Grant | Stock Option (Right to Buy) | 10.5k | $9.18 | $96.3k | | 01/09/2020 |
| 05/31/2019 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 10k | $43.02 | $430.2k | | 05/31/2019 |
| 11/29/2018 | REGENXBIO Inc. | RGNX | Exercise | Stock Option (Right to Buy) | 12.8k | $3.76 | $48.1k | | 11/29/2018 |
| 11/29/2018 | REGENXBIO Inc. | RGNX | Sale | Common Stock | 12.8k | $65.00 | $831k | | 11/29/2018 |
| 11/27/2018 | REGENXBIO Inc. | RGNX | Sale | Common Stock | 18.8k | $65.03 | $1.2M | | 11/26/2018 |
| 11/27/2018 | REGENXBIO Inc. | RGNX | Exercise | Stock Option (Right to Buy) | 883 | $49.45 | $43.7k | | 11/26/2018 |
| 11/27/2018 | REGENXBIO Inc. | RGNX | Exercise | Stock Option (Right to Buy) | 4.7k | $22.00 | $103.1k | | 11/26/2018 |
| 11/27/2018 | REGENXBIO Inc. | RGNX | Exercise | Stock Option (Right to Buy) | 6.2k | $18.85 | $117.8k | | 11/26/2018 |
| 11/27/2018 | REGENXBIO Inc. | RGNX | Exercise | Stock Option (Right to Buy) | 6.2k | $12.74 | $79.6k | | 11/26/2018 |
| 11/27/2018 | REGENXBIO Inc. | RGNX | Exercise | Stock Option (Right to Buy) | 716 | $3.76 | $2.7k | | 11/26/2018 |
| 11/26/2018 | REGENXBIO Inc. | RGNX | Exercise | Stock Option (Right to Buy) | 1.7k | $49.45 | $85.1k | | 11/26/2018 |
| 11/26/2018 | REGENXBIO Inc. | RGNX | Sale | Common Stock | 1.7k | $65.00 | $111.9k | | 11/26/2018 |
| 05/25/2018 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 12.5k | $49.45 | $618.1k | | 05/25/2018 |
| 05/24/2017 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 12.5k | $18.85 | $235.6k | | 05/24/2017 |
| 06/01/2016 | REGENXBIO Inc. | RGNX | Grant | Stock Option (Right to Buy) | 12.5k | $12.74 | $159.2k | | 06/01/2016 |
|